Carole Huntsman to sell 419 shares — Madrigal (NASDAQ: MDGL) Form 144
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Carole Huntsman submitted a Form 144 proposing the sale of 419 shares of common stock in Madrigal Pharmaceuticals. The filing lists a Restricted Stock Unit Grant with a 03/06/2026 vesting date tied to 419 shares. The filing also discloses prior sales of 340 and 570 shares on 01/26/2026.
Positive
- None.
Negative
- None.
FAQ
What does Carole Huntsman's Form 144 for MDGL report?
It reports a proposed sale of 419 shares of common stock tied to a restricted stock unit vesting on 03/06/2026. The filing lists prior sales and identifies the securities and dates without stating planned sale price.
What recent sales by Carole Huntsman are disclosed in the filing?
The filing states sales of 340 shares and 570 shares executed on 01/26/2026, with corresponding amounts of $167,422.80 and $281,916.30 shown in the excerpt.
Who is the broker or agent listed on the Form 144 for these transactions?
The excerpt lists Morgan Stanley Smith Barney LLC at 1 New York Plaza as the broker/firm associated with the securities to be sold and the Nasdaq as the market.